Stockscreener 앱 받기
20.50
8.36%
-1.87
Uniqure N V 주식(QURE)의 최신 뉴스
Will uniQure N.V. stock split again soonJuly 2025 Price Swings & Accurate Entry/Exit Alerts - mfd.ru
uniqure investor lawsuit deadline set for April 13 following FDA setback By Investing.com - Investing.com India
UniQure (QURE) Reports Positive Phase I/IIa AMT-191 Data for Fabry Disease, Shows Sustained Enzyme Activity - Finviz
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - PR Newswire
Class Action Lawsuit Announced for uniQure N.V. - Intellectia AI
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
QURE Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against uniQure N.V. - PR Newswire
uniQure (NASDAQ:QURE) Stock Price Down 9.5%What's Next? - MarketBeat
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
uniQure Faces Class Action Lawsuit Over Misleading Statements - Intellectia AI
Will uniQure N.V. benefit from green energy policiesJuly 2025 Drop Watch & Safe Capital Growth Trade Ideas - mfd.ru
UniQure N.V. (QURE) Stock Report: Exploring A 138% Potential Upside In The Biotech Arena - DirectorsTalk Interviews
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - Morningstar
Class Action Lawsuit Filed Against uniQure N.V. - Intellectia AI
uniQure N.V. (NASDAQ:QURE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
UniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsQURE - marketscreener.com
Why is uniQure N.V. stock going downMarket Trend Report & AI Powered Buy/Sell Recommendations - mfd.ru
Why uniQure N.V. stock attracts global investorsJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - mfd.ru
Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V. (QURE)Contact Kessler Topaz Meltzer & Check, LLP - PR Newswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V. Should Contact ... - bdtonline.com
UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large - GlobeNewswire
QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - PR Newswire
uniQure Faces Class Action Lawsuit Reminder for Investors - Intellectia AI
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - Benzinga
Securities Class Action Filed Against uniQURE N.V. – Investors Encouraged to Contact Kirby McInerney LLP - FinancialContent
Class Action Announcement for uniQure N.V. (QURE): Kessler - GlobeNewswire
Is uniQure N.V. exposed to political riskQuarterly Risk Review & Low Risk Entry Point Guides - mfd.ru
Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Large Losses to Contact the Firm - pharmiweb.com
Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - bdtonline.com
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Can uniQure N.V. ride the EV wave2025 Volatility Report & Reliable Volume Spike Trade Alerts - mfd.ru
UniQure Investor Sues Over Delayed Huntington’s Drug Application - Bloomberg Law News
uniQURE Faces Class Action Lawsuit - Intellectia AI
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit - The AI Journal
UNIQURE ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
uniQure N.V. (QURE) Investors: Kessler Topaz Meltzer & Check, LLP Announces That the Firm Has Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. and Encourages Investors to Contact the Firm - The AI Journal
Weekly Recap: Can uniQure NV ride the EV wavePortfolio Return Report & Reliable Intraday Trade Plans - baoquankhu1.vn
uniQure (NASDAQ:QURE) Earns Buy Rating from HC Wainwright - MarketBeat
Risk Hedge: Is BlackRock Multi Sector Income Trust benefiting from innovation trendsJuly 2025 Summary & Long-Term Growth Plans - baoquankhu1.vn
Diamond Hill Capital Management Inc. Sells 49,320 Shares of uniQure N.V. $QURE - MarketBeat
How Early AMT-191 Gene Therapy Signals Will Impact uniQure (QURE) Investors - simplywall.st
Discipline and Rules-Based Execution in QURE Response - Stock Traders Daily
uniQure reports promising data from Fabry disease gene therapy trial By Investing.com - Investing.com Nigeria
UniQure's AMT-191 Sustains Key Enzyme Activity In Fabry Disease In Phase I/IIa Trial; Stock Up - Nasdaq
Uniqure stock rises after AMT-191 gene therapy shows promising Fabry results - Investing.com Nigeria
Uniqure stock rises after AMT-191 gene therapy shows promising Fabry results By Investing.com - Investing.com South Africa
uniQure reports promising data from Fabry disease gene therapy trial - Investing.com
uniQure (QURE) Shares Promising Data on Gene Therapy for Fabry D - GuruFocus
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease - The Manila Times
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa - GlobeNewswire
uniQure (NASDAQ:QURE) Stock Price Up 8.6%What's Next? - MarketBeat
Here’s Why uniQure (QURE) Declined in Q4 - Yahoo Finance
Aug Opening: Why is uniQure NV stock going downWeekly Risk Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
uniQure (QURE) Is Down 9.4% After FDA Deems AMT-130 Data Insufficient for BLA Filing - Sahm
Stock Recap: Is uniQure NV stock risky to hold nowQuarterly Earnings Report & Expert Approved Trade Ideas - baoquankhu1.vn
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourage - GuruFocus
Update Recap: Will uniQure NV benefit from geopolitical trendsJuly 2025 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ - marketscreener.com
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - PR Newswire
1.12%
0.87%
자본화:
|
볼륨(24시간):